» Articles » PMID: 17991766

Resveratrol (trans-resveratrol, 3,5,4'-trihydroxy-trans-stilbene) Glucuronidation Exhibits Atypical Enzyme Kinetics in Various Protein Sources

Overview
Specialty Pharmacology
Date 2007 Nov 10
PMID 17991766
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The dietary polyphenol trans-resveratrol (3,5,4'-trihydroxy-trans-stilbene) is glucuronidated at the 3 and 4' positions to yield two major glucuronide conjugates, resveratrol-3-O-glucuronide (R3G) and resveratrol-4'-O-glucuronide (R4'G). The major enzymes catalyzing this conjugation reaction are members of the UDP-glucuronosyl transferase (UGT) 1A family and include UGT1A1 and UGT1A9, with minor contributions by UGT1A10. The kinetics of resveratrol glucuronidation in these three UGT1A isoforms as well as in human liver and intestinal microsomes were characterized across a wide concentration range. Atypical kinetics were observed for resveratrol glucuronidation in all the protein sources studied. The V(max) estimate per total protein for both glucuronides was higher in human intestinal microsomes compared with human liver microsomes (12.2 +/- 0.34 versus 7.4 +/- 0.25 nmol/min/mg for R3G and 8.9 +/- 0.14 versus 0.45 +/- 0.01 nmol/min/mg for R4'G). The kinetic profile for formation of R3G in both human liver and intestinal microsomes fits a substrate inhibition model, whereas that for R4'G exhibited a biphasic kinetic profile in human liver microsomes and substrate inhibition in human intestinal microsomes. In recombinant human UGT supersomes, for both glucuronides, UGT1A9 exhibited higher activity than UGT1A1, whereas the lowest activity was observed with UGT1A10. The kinetic profile for R3G exhibited substrate inhibition for all three isoforms, whereas that for R4'G differed, exhibiting substrate inhibition for UGT1A1 and UGT1A10 and Hill kinetics for UGT1A9. These results suggest that in vitro kinetics of resveratrol glucuronidation at high concentrations cannot be ignored in predicting in vivo clearance upon high-dose consumption of resveratrol.

Citing Articles

Oxyresveratrol and Gnetol Glucuronide Metabolites: Chemical Production, Structural Identification, Metabolism by Human and Rat Liver Fractions, and Anti-inflammatory Properties.

Hornedo-Ortega R, Jourdes M, Da Costa G, Courtois A, Gabaston J, Teissedre P J Agric Food Chem. 2022; 70(41):13082-13092.

PMID: 35195403 PMC: 9585577. DOI: 10.1021/acs.jafc.1c07831.


Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).

Zhou J, Argikar U, Miners J Methods Mol Biol. 2021; 2342:301-338.

PMID: 34272700 DOI: 10.1007/978-1-0716-1554-6_12.


Resveratrol Plays Protective Roles on Kidney of Uremic Rats via Activating HSP70 Expression.

Feng S, Wang J, Teng J, Fang Z, Lin C Biomed Res Int. 2020; 2020:2126748.

PMID: 32280682 PMC: 7125444. DOI: 10.1155/2020/2126748.


Comparative toxicokinetics of Trans-resveratrol and its major metabolites in Harlan Sprague Dawley rats and B6C3F1/N mice following oral and intravenous administration.

Mutlu E, Gibbs S, South N, Pierfelice J, Burback B, Germolec D Toxicol Appl Pharmacol. 2020; 394:114962.

PMID: 32205187 PMC: 7398575. DOI: 10.1016/j.taap.2020.114962.


The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced Apoptosis of Breast Cancer 4T1 Cells.

Wu H, Chen L, Zhu F, Han X, Sun L, Chen K Toxins (Basel). 2019; 11(12).

PMID: 31847250 PMC: 6950385. DOI: 10.3390/toxins11120731.